Sanofi’s bad, awful, terrible development week ends with PhIII C. diff failure
Friday marks the end of Sanofi’s bad, awful, terrible week of vaccine development news.
The pharma giant $SNY says it will terminate its late-stage program …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.